SAFE vs. FIB-4: diagnostic accuracy for clinically significant fibrosis in U.S. adults with cardiometabolic risk factors – a NHANES 2017–2020 analysis
These findings support the use of SAFE over FIB-4 as a noninvasive screening tool for significant fibrosis in patients with cardiometabolic risk factors.
Authors
- Carolina Borz-Baba (ORCID: https://orcid.org/0000-0003-3917-4932)
- Y Aydin
- Adem Aydin
Institutions
- Tulane University (US)
- St Mary's Hospital (US)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1097/meg.0000000000003161
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00